Get the Stockscreener App
26.63
4.68%
1.13
Castle Biosciences Inc stock is traded at $26.63, with a volume of 499.21K.
It is up +4.68% in the last 24 hours and up +17.49% over the past month.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
See More
Previous Close:
$25.50
Open:
$25.5
24h Volume:
499.21K
Relative Volume:
1.12
Market Cap:
$773.80M
Revenue:
$219.79M
Net Income/Loss:
$-57.47M
P/E Ratio:
-12.39
EPS:
-2.15
Net Cash Flow:
$-19.25M
1W Performance:
+11.40%
1M Performance:
+17.49%
6M Performance:
+37.95%
1Y Performance:
-19.48%
1-Day Range:
$25.29
$26.75
1-Week Range:
$23.31
$26.75
52-Week Range:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Name
Castle Biosciences Inc
Sector
Industry
Phone
866-788-9007
Address
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Compare CSTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
26.68 | 739.71M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
562.32 | 213.17B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
213.94 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
719.00 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.44 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
214.74 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Apr-30-21 | Initiated | Lake Street | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-27-19 | Reiterated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | BTIG Research | Buy |
| Aug-19-19 | Initiated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | Robert W. Baird | Outperform |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
View All
Castle Biosciences Inc Stock (CSTL) Latest News
Pattern recognition hints at Castle Biosciences Inc. upsideRate Cut & Fast Entry High Yield Tips - newser.com
Will Castle Biosciences Inc. stock remain a Wall Street favoriteLong Setup & Entry Point Confirmation Signals - newser.com
Full technical analysis of Castle Biosciences Inc. stockJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Chart based analysis of Castle Biosciences Inc. trendsStop Loss & Capital Protection Trade Alerts - newser.com
Statistical indicators supporting Castle Biosciences Inc.’s strengthJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why hedge funds are buying Castle Biosciences Inc. stockRisk Management & Daily Entry Point Alerts - newser.com
Y Intercept Hong Kong Ltd Buys Shares of 78,938 Castle Biosciences, Inc. $CSTL - MarketBeat
When is the best time to exit Castle Biosciences Inc.Weekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Quantitative breakdown of Castle Biosciences Inc. recent moveTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
Is Castle Biosciences Inc. stock attractive for income investorsQuarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com
Evaluating Castle Biosciences Inc. with trendline analysisQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Risk adjusted return profile for Castle Biosciences Inc. analyzed2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Castle Biosciences (NASDAQ:CSTL) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
What technical signals suggest for Castle Biosciences Inc. stockWeekly Profit Report & Technical Analysis for Trade Confirmation - newser.com
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Report Preview: W - GuruFocus
Zacks.com featured highlights include RadNet, Mission Produce, Castle Biosciences and FreightCar America - sharewise.com
Earnings visualization tools for Castle Biosciences Inc.Quarterly Profit Summary & Short-Term Trading Alerts - newser.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Is Castle Biosciences Inc. stock a dividend growth opportunityJuly 2025 Levels & Smart Allocation Stock Tips - newser.com
Castle Biosciences Inc. recovery potential after sell offRisk Management & Real-Time Market Trend Scan - newser.com
Castle Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
Castle Biosciences to Participate in Upcoming Investor Conferences - markets.businessinsider.com
Castle Biosciences Scheduled to Present at Stephens 27th Annual Investment Conference and Jefferies Global Healthcare Conference - Quiver Quantitative
Castle Biosciences (NASDAQ: CSTL) to present Nov. 19; live webcast and Jefferies meetings - Stock Titan
Will Castle Biosciences Inc. stock maintain growth storyJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - fcp.pa.gov.br
Castle Biosciences Inc Stock (CSTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):